Fragment screening by surface plasmon resonance.
暂无分享,去创建一个
[1] Michèle N Schulz,et al. Recent progress in fragment-based lead discovery. , 2009, Current opinion in pharmacology.
[2] M. Congreve,et al. Recent developments in fragment-based drug discovery. , 2008, Journal of medicinal chemistry.
[3] Yun Hee Cho,et al. Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. , 2006, Analytical biochemistry.
[4] Rutger H A Folmer,et al. Discovery of a novel warhead against beta-secretase through fragment-based lead generation. , 2007, Journal of medicinal chemistry.
[5] A. Hopkins,et al. Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.
[6] D. Swinney,et al. Applications of Binding Kinetics to Drug Discovery , 2012, Pharmaceutical Medicine.
[7] T Neumann,et al. SPR-based fragment screening: advantages and applications. , 2007, Current topics in medicinal chemistry.
[8] Magnus Björsne,et al. Label-Free Primary Screening and Affinity Ranking of Fragment Libraries Using Parallel Analysis of Protein Panels , 2008, Journal of biomolecular screening.
[9] Martin Stahl,et al. Tyramine fragment binding to BACE-1. , 2008, Bioorganic & medicinal chemistry letters.
[10] Tiffany Tsang,et al. Thermodynamic benchmark study using Biacore technology. , 2007, Analytical biochemistry.
[11] Kristin E. D. Coan,et al. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. , 2008, Journal of the American Chemical Society.
[12] Gianni Chessari,et al. From fragment to clinical candidate--a historical perspective. , 2009, Drug discovery today.
[13] Susanne Nyström,et al. Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library. , 2008, Journal of medicinal chemistry.